Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561702 · ClinicalTrials.gov registry record · Phase 2
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02561702 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 4 participants.
The verdict
NCT02561702, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
Charcot Marie Tooth Disease is a family of inherited peripheral neuropathies, with over 70 causative genes identified to date.1-4 Muscle cramps are frequent in CMT, affecting up to 85% of patients with some subtypes of CMT. These cramps impact quality of life and have been identified as an important therapeutic target for clinical trials in CMT.1-4 There is no FDA approved treatment for muscle cramps.5 Mexiletine is a sodium channel blocker approved for treatment of arrhythmias. As a sodium channel blocker, mexiletine offers the promise of effective therapy for muscle cramps.
Interventions
- OTHER Placebo
- DRUG Mexiletine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02561702
The ClinicalTrials.gov registry entry for NCT02561702 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02561702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02561702 about?
NCT02561702 is a clinical study titled "Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease". Charcot Marie Tooth Disease is a family of inherited peripheral neuropathies, with over 70 causative genes identified to date.1-4 Muscle cramps are frequent in CMT, affecting up to 85% of patients with some subtypes of CMT. These cramps impact quality of life and have been identified as an important...
What is the current status of trial NCT02561702?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2015-09. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02561702?
The interventions under investigation include: Placebo (OTHER), Mexiletine (DRUG).
Who is sponsoring clinical trial NCT02561702?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.